Antibodies that block B-cell activating factor (BAFF) or a proliferation inducing ligand (APRIL), and thereby prevent the differentiation of B cells to PCs, have also shown efficacy in autoimmune diseases. Here, TNFSF13B is linked to autoimmune disease.